Clinical Trial Update: A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting completion of the study of VERVE-101 in patients with heterozygous familial hypercholesterolemia and cardiovascular disease. It s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Heterozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• VERVE-101

Snippet

Sponsor: Verve Therapeutics, Inc. | Conditions: Heterozygous Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease | Phase 1 | Status: COMPLETED